Eterna Therapeutics Inc. (ERNA)
USD 0.27
(-1.0%)
USD 0.27
(-1.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 68 Thousand | - | - | - | 19.8 Million | 23.33 Million |
| Cost of Revenue | 236 Thousand | 497 Thousand | 459 Thousand | 98 Thousand | 7.84 Million | 8.38 Million |
| Gross Profit | -168 Thousand | -497 Thousand | -459 Thousand | -98 Thousand | 11.96 Million | 14.95 Million |
| Operating Expenses | 19.38 Million | 27.22 Million | 27.42 Million | 7.24 Million | 13.17 Million | 14.48 Million |
| Selling, General and Administrative Expenses | 14.58 Million | 16.83 Million | 14.72 Million | 3.29 Million | 13.14 Million | 14.41 Million |
| Research and Development Expenses | 5.92 Million | 10.39 Million | 12.7 Million | 3.95 Million | 26 Thousand | 72 Thousand |
| Other Expenses | 461 Thousand | -1.17 Million | 899 Thousand | - | - | - |
| Cost and Expenses | 21.2 Million | 27.22 Million | 27.42 Million | 7.24 Million | 21.01 Million | 22.87 Million |
| Operating Income | -21.13 Million | -33.21 Million | 68.34 Million | -7.24 Million | -1.21 Million | 464 Thousand |
| Interest Expense | 614 Thousand | 30 Thousand | 74 Thousand | 43 Thousand | 249 Thousand | 389 Thousand |
| Income Tax Expense | -3000.00 | 45 Thousand | 5000.00 | -19.19 Million | 27 Thousand | -64 Thousand |
| Earnings before Tax | -21.67 Million | -24.53 Million | -122.3 Million | -7.29 Million | -2.02 Million | -323 Thousand |
| Net Income | -21.66 Million | -24.57 Million | -122.3 Million | 11.9 Million | -2.04 Million | -259 Thousand |
| Earnings Per Share Basic | -4.08 | -8.06 | -56.49 | 27.08 | -28.48 | -3.85 |
| Earnings Per Share Diluted | -4.08 | -8.06 | -56.49 | 27.08 | -28.48 | -3.85 |
| Weighted Average Shares Outstanding | 5.31 Million | 3.05 Million | 2.16 Million | 439.7 Thousand | 71.87 Thousand | 67.2 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 5.31 Million | 3.05 Million | 2.16 Million | 439.7 Thousand | 71.87 Thousand | 67.2 Thousand |
| Gross Margin | -2.47 | - | - | - | 0.60 | 0.64 |
| EBIT Margin | -293.15 | - | - | - | 0.10 | 0.14 |
| Profit Margin | -318.65 | - | - | - | -0.10 | -0.01 |
| EBITDA | -19.93 Million | -33.21 Million | -121.94 Million | -7.15 Million | 1.95 Million | 3.22 Million |
| Earnings Before Tax Margin | -310.81 | - | - | - | -0.06 | 0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 47 Thousand | 47 Thousand | 17 Thousand | 68 Thousand | 51 Thousand | - |
| Cost of Revenue | 673 Thousand | 602 Thousand | 547 Thousand | 1.35 Million | 120 Thousand | 63 Thousand |
| Gross Profit | -626 Thousand | -555 Thousand | -530 Thousand | -1.29 Million | -69 Thousand | -63 Thousand |
| Operating Expenses | 4.3 Million | 5.23 Million | 5.23 Million | 19.38 Million | 5.43 Million | 4.08 Million |
| Selling, General and Administrative Expenses | 3.31 Million | 3.77 Million | 4.02 Million | - | 3.97 Million | 2.51 Million |
| Research and Development Expenses | 987 Thousand | 1.45 Million | 1.21 Million | - | 1.45 Million | 1.57 Million |
| Other Expenses | - | - | -53 Thousand | -334 Thousand | - | -280 Thousand |
| Cost and Expenses | 4.97 Million | 5.83 Million | 5.78 Million | 20.74 Million | 5.55 Million | 4.08 Million |
| Operating Income | -4.93 Million | -5.78 Million | -5.76 Million | -20.67 Million | -5.5 Million | -4.54 Million |
| Interest Expense | 797 Thousand | 786 Thousand | 388 Thousand | 614 Thousand | 114 Thousand | - |
| Income Tax Expense | 3000.00 | 4000.00 | -4000.00 | -3000.00 | -8000.00 | 4000.00 |
| Earnings before Tax | -5.52 Million | -6.64 Million | -6.15 Million | -21.67 Million | -5.59 Million | -4.5 Million |
| Net Income | -5.52 Million | -6.64 Million | -6.15 Million | -21.66 Million | -5.59 Million | -4.5 Million |
| Earnings Per Share Basic | -1.02 | -1.23 | -1.14 | - | -1.03 | -0.85 |
| Earnings Per Share Diluted | -1.02 | -1.23 | -1.14 | - | -1.03 | -0.85 |
| Weighted Average Shares Outstanding | 5.41 Million | 5.41 Million | 5.41 Million | 5.31 Million | 5.41 Million | 5.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.41 Million | 5.41 Million | 5.41 Million | 5.31 Million | 5.41 Million | 5.3 Million |
| Gross Margin | -13.32 | -11.81 | -31.18 | -18.99 | -1.35 | - |
| EBIT Margin | -92.62 | -111.62 | -310.82 | - | -97.80 | - |
| Profit Margin | -117.64 | -141.43 | -361.94 | -318.65 | -109.63 | - |
| EBITDA | -4.35 Million | -5.24 Million | -5.28 Million | - | -4.98 Million | -3.86 Million |
| Earnings Before Tax Margin | -104.91 | -123.13 | -339.12 | -304.03 | -107.94 | - |
SNA
ARBV
3202
WMNNF
RGBD
TRX